Environmental Clean Technologies Limited (ASX:ECT) has commenced a strategic commercialisation review of its proprietary COLDry® technology, assessing a range of pathways to bring it to market and maximise shareholder value. COLDry is a low-temperature lignite processing technology capable of producing value-added products for applications including agriculture.

🌱 Commercialisation review underway: Environmental Clean Technologies has engaged RSM Corporate Australia to provide an independent assessment of potential commercialisation pathways for COLDry, including licensing opportunities, partnerships, alternative applications and commercial structures.
🏭 Expanding market opportunities: The review will examine both Environmental Clean Technologies’ existing commercial relationships and broader opportunities for COLDry.
🤝 Strategic partnerships under review: Environmental Clean Technologies will also assess its ongoing relationship with Zero Quest, which is developing fertiliser products incorporating COLDry technology, as part of the broader evaluation of future commercial opportunities.

“ECT has spent more than two decades developing COLDry and we believe the technology has reached an important stage in its commercial development. This review is intended to ensure the Board considers the full range of opportunities available to maximise value from the technology.” - Environmental Clean Technologies Executive Chairman Faldi Ismail

The biggest IPO in history starts trading on Friday, SpaceX, priced at $135 a share with a valuation of about USD $1.75 trillion, making it one of the ten most valuable companies on in the world. Last year SpaceX made $18.7 billion in revenue but lost almost $5 billion. It’s high-speed internet group Starlink prints money, but the AI side of the business is burning billions each quarter.

Morningstar says SpaceX is worth $780 billion, which is almost $1 trillion lower than where the IPO pricing landed. When record demand meets a record price, who is right — the crowd, or the calculators? Space Exploration Technologies Corp (NASDAQ:SPCX) will list on the Nasdaq with a ticker code of SPCX.

#SpaceX #IPO #ElonMusk #stocks #tech

Australia’s media landscape is changing with deals around every corner. This week Vinyl Group (ASX:VNL) has announced two acquisitions, starting the week with buying Pedestrian then following up with Time Out.

The Pedestrian acquisition is being acquired from Nine Digital for a nominal consideration. Vinyl says Pedestrian is one of Australia’s most recognised original youth media brands and Time Out one of the world’s most iconic culture brands.

This comes after Vinyl bought Val Morgan Digital, the local publisher of Buzzfeed, Ladbible and PopSugar, for $10.5m in cash and shares in March 2026. Vinyl believes the future of media is not just reaching big audiences but integrating brands and cultural moments.

#media #finance #money #stocks #future

Imugene Limited (ASX:IMU) has received FDA Fast Track Designation for its allogeneic CAR T-cell therapy azer-cel in two blood cancer indications, relapsed or refractory Chronic Lymphocytic Leukaemia/Small Lymphocytic Lymphoma (CLL/SLL) and relapsed or refractory Marginal Zone Lymphoma (MZL). This development supports an expedited regulatory pathway for the company’s azer-cel therapy.

🩸 FDA Fast Track Designation: azer-cel has been granted Fast Track Designation for both CLL/SLL and MZL, providing opportunities for more frequent FDA engagement, rolling review and potential eligibility for Accelerated Approval and Priority Review.
📊 Encouraging clinical results: Phase 1b data showed a 100% overall response rate (ORR) in the CAR T-naive CLL/SLL cohort, while updated MZL data demonstrated an 83% ORR, including four complete responses.
⚡ Off-the-shelf CAR T approach: azer-cel is a donor-derived, CD19-targeting CAR T-cell therapy designed to be available within days, potentially overcoming the manufacturing delays associated with traditional autologous CAR T treatments.

“FDA Fast Track Designation for both CLL/SLL and MZL reflects the meaningful clinical activity we are seeing with azer-cel across multiple B-cell malignancies.” - Imugene Managing Director and CEO Leslie Chong

Chariot Resources (ASX:CC9) has significantly expanded its strategic position in the McDermitt Caldera after staking 573 additional claims at its Resurgent East Project in Nevada-Oregon. The move nearly doubles the Company’s landholding following a disciplined consolidation during the lithium downturn and strengthens its exposure alongside major neighbouring developments including Thacker Pass and Jindalee’s McDermitt Project. Chariot Resources Managing Director Shanthar Pathmanathan joins The Stock Network’s Lel Smits to discuss the expanded land position, the improving lithium market and the Company’s plans to unlock the potential of Resurgent.

🪓 Strategic expansion at Resurgent East
🛘 Positioned in a globally significant lithium district
🚀 Preparing for the next phase of growth

Did you know some stocks market have an emergency off switch and on Monday, South Korea used theirs. The Kospi, Korea`s main index, was in freefall. Down more than 8% within the first hour.

So the exchange did something drastic and stopped everything. That`s called a circuit breaker. Here`s how Korea`s works: if the index stays 8% or more below yesterday`s close for a full minute trading halts for 20 minutes. No buying. No selling. Forced time-out.

Falling prices trigger automatic selling, which triggers more falling. Machines panic faster than people. America has one too, the US market freezes if the S&P 500 falls 7%, but Australia doesn`t. The ASX made a deliberate choice to have no master off switch. Instead, it pauses individual stocks that move too violently, and lets the market as a whole keep trading.

The thinking: in a panic, investors need the exits open, not locked.

#finance #stocks #ASX #investing #fintok

Exchange Traded Funds (ETFs) have become one of the fastest-growing investment vehicles globally, yet many investors are still unsure how they work, how to use them, and where to start. In this ETF Education Spotlight, presented in partnership with Women in ETFs, The Stock Network’s Lel Smits is joined by Claudia Catalanotto, Sales Operations Manager at VanEck, to break down the fundamentals of ETFs, explain why they’ve become so popular with investors, and provide practical education for those looking to better understand the product.

📘 ETF 101: What is an ETF and why are they growing so quickly?
🧩 Understanding the different types of ETFs
💡 What investors should know before buying an ETF
📋 Common misconceptions around ETFs
📈 Building a portfolio with ETFs

Please note: investing in ETFs carries risks. Not personal advice.

Boresight has listed on the ASX with the ticker code of BST. The company is a provider of Target Drones to western and allied militaries. These Drones emulate real world threats in a reliable and repeatable manner, and are sold at a price point that supports live-fire, testing, destructive evaluation and training without placing undue pressure on defence budgets. Considerable investment has already been made into the optimisation of the manufacture of the Target Drones. Boresight plans to use the proceeds of its IPO raise to fund expansion of its engineering and production teams, ramp up production in the United States, increase its additive manufacturing capacity and further vertically integrate operations.

Media: The Stock Network, @lelsmits